Status | Study |
Recruiting |
Study Name: Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer Condition: Laryngeal Cancer Date: 2012-06-29 Interventions: Drug: AT-101 Patients will rec |
Completed |
Study Name: Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of Life Condition: Cancer of the Larynx Date: 2012-05-24 |
Completed |
Study Name: Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance Condition: Laryngeal Neoplasms Date: 2010-12-09 Interventions: Procedure: Transoral robot-assisted tumor resection using the da Vinci robot Transoral robot-assisted tu |
Terminated |
Study Name: TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors Condition: Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer Date: 2010-11-22 Interventions: Radiation: carbon ion boost patients receive induction chemotherapy with TPF for a maximum of 3 cycles f |
Completed |
Study Name: Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer Condition: Squamous Cell Carcinoma Laryngeal Cancer Date: 2010-03-17 |
Recruiting |
Study Name: Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer Condition: Larynx Cancer Date: 2010-01-12 Interventions: Procedure: laryngoscopy Treatm |
Completed |
Study Name: Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer Condition: Head and Neck Cancer Pharyngeal Cancer Date: 2009-01-21 Interventions: Behavioral: Nutrition Counseling |
Active, not recruiting |
Study Name: Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx Condition: Head and Neck Cancer Date: 2008-05-08 Interventions: Drug: HPPH Given IV |
Terminated |
Study Name: Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) Condition: Cancer of Larynx Date: 2007-12-12 Interventions: Drug: Cisplatin 1. Day 1: 100 |
Completed |
Study Name: Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) Condition: Squamous Cell Carcinoma of the Hypopharynx Larynx Carcinoma Date: 2007-07-27 Interventions: Radiation: Radiation Radiation |